SpencerTrask Specialty Group

Spencer Trask Specialty Group is a venture capital and business development firm that focuses on the formation and financing of high-impact technology and life science companies. As a division of Spencer Trask & Co., the group is recognized for its 'venture-building' model, where it often takes a foundational role in the creation of new enterprises. Notable successes include the founding and funding of Myriad Genetics, which pioneered genetic testing for breast cancer, and Genomics Health. The firm specializes in identifying breakthrough scientific discoveries and providing the strategic capital and leadership necessary to bring them to the global market. Their investment focus spans across biotechnology, medical devices, and healthcare information technology. Led by Chairman Kevin Kimberlin, the group has a long history of partnering with leading research institutions to commercialize intellectual property.